See more : China Auto Logistics Inc. (CALI) Income Statement Analysis – Financial Results
Complete financial analysis of Pfizer Limited (PFIZER.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pfizer Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Twenty Seven Co. Limited (TSC.AX) Income Statement Analysis – Financial Results
- Lapidoth Capital Ltd (LAPD.TA) Income Statement Analysis – Financial Results
- Bougainville Copper Limited (BOC.AX) Income Statement Analysis – Financial Results
- Goldlion Holdings Limited (GLLHF) Income Statement Analysis – Financial Results
- BlackRock MuniHoldings New Jersey Quality Fund, Inc. (MUJ) Income Statement Analysis – Financial Results
Pfizer Limited (PFIZER.NS)
About Pfizer Limited
Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.93B | 24.25B | 26.11B | 22.38B | 21.52B | 20.81B | 19.68B | 19.66B | 19.95B | 18.28B | 10.04B | 9.48B | 10.17B | 0.00 | 7.72B | 6.82B | 6.77B | 6.67B | 6.30B | 5.93B |
| Cost of Revenue | 7.98B | 8.74B | 9.48B | 7.98B | 7.92B | 7.48B | 7.40B | 7.97B | 7.85B | 7.40B | 3.75B | 3.33B | 3.60B | 0.00 | 3.22B | 2.71B | 2.34B | 2.57B | 2.40B | 2.58B |
| Gross Profit | 13.95B | 15.51B | 16.63B | 14.41B | 13.59B | 13.34B | 12.29B | 11.70B | 12.10B | 10.87B | 6.29B | 6.14B | 6.58B | 0.00 | 4.50B | 4.11B | 4.43B | 4.10B | 3.89B | 3.35B |
| Gross Profit Ratio | 63.60% | 63.97% | 63.68% | 64.36% | 63.17% | 64.07% | 62.42% | 59.49% | 60.64% | 59.49% | 62.63% | 64.82% | 64.66% | 0.00% | 58.32% | 60.28% | 65.41% | 61.47% | 61.82% | 56.57% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 275.00M | 205.38M | 173.99M | 147.57M | 175.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.48B | 2.65B | 1.29B | 972.90M | 867.10M | 742.90M | 705.60M | 776.87M | 713.35M | 714.81M | 507.36M | 539.15M | 420.50M | 0.00 | 868.09M | 812.89M | 0.00 | 745.23M | 745.66M | 791.31M |
| Selling & Marketing | 855.90M | 615.90M | 1.48B | 1.38B | 1.54B | 1.53B | 1.43B | 1.53B | 1.74B | 1.56B | 876.14M | 1.00B | 1.06B | 0.00 | 520.21M | 458.02M | 0.00 | 450.80M | 338.90M | 337.12M |
| SG&A | 4.34B | 3.26B | 2.77B | 2.35B | 2.40B | 2.27B | 2.14B | 2.31B | 2.45B | 2.28B | 1.38B | 1.54B | 1.48B | 0.00 | 1.39B | 1.27B | 0.00 | 1.20B | 1.08B | 1.13B |
| Other Expenses | 0.00 | 8.48B | 6.63B | 6.02B | 6.44B | 107.90M | 88.90M | 82.48M | 113.35M | 216.62M | 153.66M | 144.52M | 119.27M | 0.00 | -109.18M | 2.08B | 321.68M | -233.68M | -233.68M | -192.24M |
| Operating Expenses | 4.34B | 8.48B | 9.40B | 8.37B | 8.84B | 8.37B | 7.94B | 8.82B | 8.92B | 8.33B | 3.91B | 4.33B | 4.46B | 0.00 | 2.29B | 2.00B | 321.68M | 2.24B | 2.62B | 2.48B |
| Cost & Expenses | 12.32B | 17.21B | 18.88B | 16.35B | 16.76B | 15.85B | 15.34B | 16.79B | 16.77B | 15.74B | 7.66B | 7.67B | 8.06B | 0.00 | 5.51B | 4.70B | 2.66B | 4.81B | 5.03B | 5.06B |
| Interest Income | 1.72B | 854.90M | 489.40M | 387.40M | 1.30B | 1.26B | 982.70M | 877.08M | 563.34M | 445.36M | 857.35M | 891.18M | 786.30M | 0.00 | 522.60M | 0.00 | 582.46M | 403.43M | 83.19M | 74.85M |
| Interest Expense | 154.30M | 133.90M | 104.90M | 151.10M | 108.50M | 12.90M | 4.20M | 9.57M | 5.23M | 7.69M | 3.64M | 2.40M | 5.90M | 0.00 | 0.00 | 0.00 | 152.00K | 715.00K | 84.76M | 8.12M |
| Depreciation & Amortization | 622.80M | 1.04B | 1.14B | 1.08B | 1.02B | 700.00M | 648.60M | 615.40M | 1.24B | 1.31B | 79.70M | 80.18M | 95.61M | 0.00 | 82.88M | 111.22M | 95.85M | 130.71M | 138.46M | 102.57M |
| EBITDA | 8.24B | 9.42B | 8.97B | 7.92B | 7.55B | 7.32B | 6.14B | 5.80B | 5.28B | 4.00B | 2.53B | 7.02B | 2.88B | 0.00 | 2.29B | 2.22B | 4.78B | 1.73B | 1.41B | 973.14M |
| EBITDA Ratio | 37.56% | 37.53% | 34.23% | 35.19% | 33.59% | 33.71% | 30.86% | 22.67% | 25.40% | 24.57% | 34.43% | 30.79% | 30.52% | 0.00% | 29.68% | 32.62% | 70.68% | 29.87% | 22.38% | 16.41% |
| Operating Income | 9.61B | 8.04B | 7.79B | 6.78B | 6.19B | 4.97B | 4.35B | 2.87B | 3.18B | 2.54B | 2.38B | 1.81B | 2.12B | 0.00 | 2.21B | 2.11B | 4.10B | 1.86B | 1.27B | 870.57M |
| Operating Income Ratio | 43.83% | 33.17% | 29.82% | 30.31% | 28.79% | 23.86% | 22.09% | 14.61% | 15.94% | 13.90% | 23.73% | 19.10% | 20.79% | 0.00% | 28.61% | 30.98% | 60.66% | 27.91% | 20.18% | 14.68% |
| Total Other Income/Expenses | -2.15B | -3.29B | -4.07B | -3.42B | -2.58B | -2.27B | -2.53B | -2.36B | -3.20B | -158.52M | 1.01B | 5.13B | 901.26M | 0.00 | -118.23M | 2.08B | 384.60M | -265.10M | -152.07M | -125.51M |
| Income Before Tax | 7.46B | 8.24B | 7.73B | 6.69B | 6.42B | 6.60B | 5.48B | 5.17B | 4.02B | 2.38B | 3.40B | 6.94B | 2.78B | 0.00 | 2.10B | 4.19B | 4.51B | 1.63B | 1.12B | 745.06M |
| Income Before Tax Ratio | 34.02% | 33.98% | 29.61% | 29.87% | 29.86% | 31.70% | 27.83% | 26.29% | 20.16% | 13.02% | 33.81% | 73.18% | 27.28% | 0.00% | 27.19% | 61.48% | 66.70% | 24.39% | 17.76% | 12.56% |
| Income Tax Expense | 1.95B | 2.00B | 1.60B | 1.71B | 1.33B | 2.31B | 1.88B | 1.80B | 1.79B | 1.38B | 1.19B | 1.91B | 929.23M | 0.00 | 731.27M | 1.20B | 1.11B | 563.10M | 411.28M | 299.18M |
| Net Income | 5.51B | 6.24B | 6.13B | 4.98B | 5.09B | 4.29B | 3.60B | 3.37B | 2.23B | 698.19M | 2.21B | 5.03B | 1.69B | 0.00 | 1.37B | 3.00B | 3.40B | 1.06B | 707.33M | 445.88M |
| Net Income Ratio | 25.14% | 25.73% | 23.46% | 22.23% | 23.66% | 20.61% | 18.29% | 17.13% | 11.17% | 3.82% | 21.99% | 53.08% | 16.66% | 0.00% | 17.72% | 43.95% | 50.24% | 15.95% | 11.23% | 7.52% |
| EPS | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | 21.93 | 74.01 | 168.63 | 61.87 | 0.00 | 45.87 | 100.24 | 113.94 | 35.63 | 23.70 | 14.94 |
| EPS Diluted | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | 21.93 | 74.01 | 168.63 | 61.87 | 0.00 | 45.87 | 100.24 | 113.94 | 35.63 | 23.70 | 14.94 |
| Weighted Avg Shares Out | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M |
| Weighted Avg Shares Out (Dil) | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 45.75M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M | 29.84M |
Source: https://incomestatements.info
Category: Stock Reports